• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

良性前列腺增生中的炎症:与前列腺特异性抗原值的相关性。

Inflammation in benign prostatic hyperplasia: correlation with prostate specific antigen value.

作者信息

Irani J, Levillain P, Goujon J M, Bon D, Doré B, Aubert J

机构信息

Department of Urology, Centre Hospitalier Universitaire La Miletrie, Poitiers, France.

出版信息

J Urol. 1997 Apr;157(4):1301-3. doi: 10.1016/s0022-5347(01)64957-7.

DOI:10.1016/s0022-5347(01)64957-7
PMID:9120926
Abstract

PURPOSE

We attempted to identify morphological parameters of benign prostatic hyperplastic inflammation that correlate with pre-biopsy prostate specific antigen (PSA) concentrations.

MATERIALS AND METHODS

Patients undergoing prostate biopsy at our department were prospectively studied between January 1995 and January 1996. preoperative blood and 24-hour urine samples were measured for PSA. Biopsy samples harboring exclusively benign prostatic tissue were graded on a 4-point scale for inflammation (0-no inflammatory cells, 1-scattered inflammatory cell infiltrate, 2-nonconfluent lymphoid nodules and 3-large inflammatory areas with confluence of infiltrate) and aggressiveness (0-no contact between inflammatory cells and glandular epithelium; 1-contact between inflammatory cell infiltrate and glandular epithelium; 2-clear but limited, that is less than 25% of the examined material, glandular epithelium disruption, and 3-glandular epithelium disruption on more than 25% of the examined material).

RESULTS

A total of 66 patients with exclusively benign prostatic tissue on prostate biopsies was analyzed. Difference between inflammation graded groups was not significant when considering serum or urinary PSA. There was a significant correlation between aggressiveness grading and serum PSA (rho = 0.51, p < 0.0001), whereas aggressiveness grading and urinary PSA did not correlate (rho = -0.06, p = 0.6).

CONCLUSIONS

Prostatic subclinical inflammation is not associated with high urinary PSA. Unless associated with glandular epithelial disruption, density of prostatic interstitial inflammatory cell infiltrate is not significantly correlated with serum PSA concentration. We believe that this issue should be considered when interpreting a prostate biopsy.

摘要

目的

我们试图确定与活检前前列腺特异性抗原(PSA)浓度相关的良性前列腺增生性炎症的形态学参数。

材料与方法

对1995年1月至1996年1月在我院接受前列腺活检的患者进行前瞻性研究。术前检测血液和24小时尿液样本中的PSA。仅含有良性前列腺组织的活检样本按炎症(0级-无炎症细胞,1级-散在炎症细胞浸润,2级-非融合性淋巴结节,3级-有浸润融合的大炎症区域)和侵袭性(0级-炎症细胞与腺上皮无接触;1级-炎症细胞浸润与腺上皮接触;2级-清晰但有限,即少于25%的检查材料出现腺上皮破坏,3级-超过25%的检查材料出现腺上皮破坏)进行4级评分。

结果

共分析了66例前列腺活检仅含良性前列腺组织的患者。在考虑血清或尿液PSA时,炎症分级组之间的差异不显著。侵袭性分级与血清PSA之间存在显著相关性(rho = 0.51,p < 0.0001),而侵袭性分级与尿液PSA无相关性(rho = -0.06,p = 0.6)。

结论

前列腺亚临床炎症与高尿液PSA无关。除非与腺上皮破坏相关,前列腺间质炎症细胞浸润密度与血清PSA浓度无显著相关性。我们认为在解读前列腺活检结果时应考虑这一问题。

相似文献

1
Inflammation in benign prostatic hyperplasia: correlation with prostate specific antigen value.良性前列腺增生中的炎症:与前列腺特异性抗原值的相关性。
J Urol. 1997 Apr;157(4):1301-3. doi: 10.1016/s0022-5347(01)64957-7.
2
Inflammation in prostate biopsies of men without prostatic malignancy or clinical prostatitis: correlation with total serum PSA and PSA density.无前列腺恶性肿瘤或临床前列腺炎男性前列腺活检中的炎症:与总血清前列腺特异性抗原及前列腺特异性抗原密度的相关性
Eur Urol. 2000 Apr;37(4):404-12. doi: 10.1159/000020161.
3
The correlation between serum prostate specific antigen levels and asymptomatic inflammatory prostatitis.血清前列腺特异性抗原水平与无症状性炎症性前列腺炎之间的相关性
Int Urol Nephrol. 2007;39(3):859-63. doi: 10.1007/s11255-006-9125-2. Epub 2006 Nov 17.
4
Elevated serum prostate specific antigen (PSA) related to asymptomatic prostatic inflammation.血清前列腺特异性抗原(PSA)升高与无症状性前列腺炎有关。
Acta Urol Belg. 1998 Oct;66(3):1-2.
5
Serum-to-urinary prostate-specific antigen ratio: a potential means of distinguishing benign prostatic hyperplasia from prostate cancer.血清与尿液前列腺特异性抗原比值:一种区分良性前列腺增生与前列腺癌的潜在方法。
Eur Urol. 1996;29(4):407-12. doi: 10.1159/000473788.
6
Increased prostate-specific antigen in subclinical prostatitis: the role of aggressiveness and extension of inflammation.亚临床前列腺炎中前列腺特异性抗原升高:炎症侵袭性和范围的作用。
Urol Int. 2003;71(2):160-4. doi: 10.1159/000071839.
7
Relationship between serum prostate specific antigen and histological prostatitis in patients with benign prostatic hyperplasia.良性前列腺增生患者血清前列腺特异性抗原与组织学前列腺炎的关系。
Prostate. 1994 Aug;25(2):91-6. doi: 10.1002/pros.2990250206.
8
Percent of free serum prostate-specific antigen and histological findings in patients undergoing open prostatectomy for benign prostatic hyperplasia.接受开放性前列腺切除术治疗良性前列腺增生患者的游离血清前列腺特异性抗原百分比及组织学结果
Eur Urol. 1999 Dec;36(6):621-30. doi: 10.1159/000020057.
9
Relationship between changes in prostate-specific antigen and the percent of prostatic epithelium in men with benign prostatic hyperplasia.良性前列腺增生男性中前列腺特异性抗原变化与前列腺上皮百分比之间的关系。
Urology. 1995 May;45(5):795-800. doi: 10.1016/s0090-4295(99)80086-7.
10
Asymptomatic prostatic inflammation in men with clinical BPH and erectile dysfunction affects the positive predictive value of prostate-specific antigen.患有临床良性前列腺增生症和勃起功能障碍的男性的无症状前列腺炎症会影响前列腺特异性抗原的阳性预测值。
Urol Oncol. 2014 Oct;32(7):946-51. doi: 10.1016/j.urolonc.2014.03.004. Epub 2014 Jul 2.

引用本文的文献

1
The Novel Histological Prostatic Inflammation Score Helps Defining the Association Between Stromal and Glandular Inflammation with the Risk of Prostate Cancer at Prostate Biopsy.新型组织学前列腺炎症评分有助于确定前列腺活检时基质和腺性炎症与前列腺癌风险之间的关联。
Diagnostics (Basel). 2025 Jan 13;15(2):166. doi: 10.3390/diagnostics15020166.
2
Analysis of Inflammatory Features in Suspicious Lesions for Significant Prostate Cancer on Magnetic Resonance Imaging-Are They Mimickers of Prostate Cancer?磁共振成像上可疑显著前列腺癌病变的炎症特征分析——它们是前列腺癌的模仿者吗?
Cancers (Basel). 2024 Dec 27;17(1):53. doi: 10.3390/cancers17010053.
3
Development and validation of a clinical nomogram to predict prostatic inflammation in men with lower urinary tract symptoms.
预测下尿路症状男性前列腺炎症的临床列线图的开发与验证
Prostate Cancer Prostatic Dis. 2025 Jun;28(2):405-410. doi: 10.1038/s41391-024-00857-5. Epub 2024 Jul 6.
4
Chronic inflammation in benign prostatic hyperplasia: Pathophysiology and treatment options.良性前列腺增生中的慢性炎症:病理生理学和治疗选择。
Int J Urol. 2024 Sep;31(9):968-974. doi: 10.1111/iju.15518. Epub 2024 Jun 27.
5
The Blood-prostate Barrier: An Obstacle to Drug Delivery into the Prostate.血-前列腺屏障:药物输送至前列腺的障碍。
Curr Drug Deliv. 2025;22(4):401-412. doi: 10.2174/1567201821666230807152520.
6
Improving Whole Tomato Transformation for Prostate Health: Benign Prostate Hypertrophy as an Exploratory Model.改善番茄整体转化用于前列腺健康:良性前列腺增生作为探索模型。
Int J Mol Sci. 2023 Mar 17;24(6):5795. doi: 10.3390/ijms24065795.
7
Inflammation and Prostate Cancer: Pathological Analysis from Pros-IT CNR 2.炎症与前列腺癌:来自意大利国家研究委员会2的前瞻性炎症和肿瘤学队列研究的病理分析
Cancers (Basel). 2023 Jan 19;15(3):630. doi: 10.3390/cancers15030630.
8
Clinical analysis of transurethral holmium laser enucleation in the treatment of benign prostatic hyperplasia with prostatic inflammation: A prospective research study.经尿道钬激光剜除术治疗合并前列腺炎的良性前列腺增生症的临床分析:一项前瞻性研究
Front Surg. 2023 Jan 6;9:1026657. doi: 10.3389/fsurg.2022.1026657. eCollection 2022.
9
Fibromodulin Gene Variants () as Potential Biomarkers for Prostate Cancer and Benign Prostatic Hyperplasia.纤维调凝蛋白基因变异 () 作为前列腺癌和良性前列腺增生的潜在生物标志物。
Dis Markers. 2022 May 31;2022:5215247. doi: 10.1155/2022/5215247. eCollection 2022.
10
Targeting CXCL12/CXCR4 Signaling with AMD3100 Might Selectively Suppress CXCR4+ T-Cell Chemotaxis Leading to the Alleviation of Chronic Prostatitis.使用AMD3100靶向CXCL12/CXCR4信号通路可能会选择性抑制CXCR4+ T细胞趋化作用,从而缓解慢性前列腺炎。
J Inflamm Res. 2022 Apr 21;15:2551-2566. doi: 10.2147/JIR.S352336. eCollection 2022.